Delivery Order SPE2DX22D0010-SPE2D826FAV16
- Not listed
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $10,441.56 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The U.S. Defense Department's Medical Supply Chain awarded a $11,313.88 delivery order to AmerisourceBergen Drug Corp on October 1, 2025, for the supply of Nucynta ER Tabs 100mg, a controlled-release pain management pharmaceutical. This competitive, firm fixed-price delivery order is scheduled for completion by October 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed-price delivery order, valued at $7,938.87, represents a non-competitive set-aside contract and is scheduled for completion by October 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The U.S. Defense Department's Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 30, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. The contract ceiling value is $5,313.94, with an ultimate completion date of October 1, 2025. This is a non-set-aside award issued competitively to the Conshohocken, Pennsylvania-based pharmaceutical distributor, which serves as a critical vendor for federal medical procurement...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Nucynta Tabs 50mg (tapentadol), a Schedule II opioid pain medication. This firm fixed-price delivery order, valued at $13,592.97, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, which carries a ceiling value of $999,999,999.00 through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,205.75 firm fixed-price delivery order by the Defense Logistics Agency on June 2, 2025, for Nucynta ER 200 mg tablets (60-count supply). The contract, which carries an ultimate completion date of June 3, 2025, represents a non-competitive award and serves the federal medical supply chain supporting military and veteran healthcare systems. This delivery order is issued...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $11,315.96 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg, a pain management pharmaceutical. Issued on August 27, 2025, with an ultimate completion date of August 28, 2025, this firm fixed-price delivery order represents a competitive award with no set-aside designation. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $11,234.27 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,288.63 on July 25, 2025, for the supply of Nucynta Tabs 50mg under a firm fixed price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by July 28, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Nucynta ER Tabs 250mg, a controlled-release pain management pharmaceutical. This firm fixed-price delivery order, valued at $8,619.04 with an ultimate completion date of June 2, 2025, represents a non-competitive award executed under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office located in Conshohocken,...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAV16Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Nucynta Tabs 50mg, a prescription opioid pain management medication. This firm fixed-price delivery order, valued at approximately $9.8K, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The contract was competitively awarded without set-aside designation to the Conshohocken, Pennsylvania-based pharmaceutical distributor, reflecting the company's established capability to meet federal medical procurement requirements. AmerisourceBergen Drug Corp serves as a critical pharmaceutical vendor for military and veteran healthcare systems, supplying a comprehensive range of medications and medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers. The delivery order is set to be completed by November 5, 2025, with performance occurring at the company's Corporate Office location in Conshohocken, Pennsylvania. This award exemplifies the Defense Logistics Agency's ongoing pharmaceutical procurement strategy, which anticipates establishing multiple regional contracts to ensure reliable supply of specialized medical products supporting military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 11/4/25 |